Europe Antiandrogen Monotherapy Market Research Report Forecast 2017-2022

July 2017 | 116 pages | ID: EFEB5621BC4EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Antiandrogen Monotherapy Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Antiandrogen Monotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antiandrogen Monotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Antiandrogen Monotherapy Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Europe Antiandrogen Monotherapy Market Analysis by Product:

• Type 1
• Type 2
• Type 3

Europe Antiandrogen Monotherapy Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Classification of Antiandrogen Monotherapy
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Antiandrogen Monotherapy
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Antiandrogen Monotherapy Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Antiandrogen Monotherapy (2012-2022)
  1.5.1 Europe Antiandrogen Monotherapy Sales and Growth Rate (2012-2022)
  1.5.2 Europe Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON ANTIANDROGEN MONOTHERAPY INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS

3.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Antiandrogen Monotherapy Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Antiandrogen Monotherapy Market Competition by Manufacturers
  5.1.1 Europe Antiandrogen Monotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Antiandrogen Monotherapy (Volume and Value) by Type
  5.2.1 Europe Antiandrogen Monotherapy Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
5.3 Europe Antiandrogen Monotherapy (Volume and Value) by Countries
  5.3.1 Europe Antiandrogen Monotherapy Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Antiandrogen Monotherapy Revenue and Market Share by Countries (2012-2017)
5.4 Europe Antiandrogen Monotherapy (Volume) by Application

6 GERMANY ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Antiandrogen Monotherapy Sales and Value (2012-2017)
  6.1.1 Germany Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  6.1.2 Germany Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Antiandrogen Monotherapy Sales Price Trend (2012-2017)
6.2 Germany Antiandrogen Monotherapy Sales and Market Share by Manufacturers
6.3 Germany Antiandrogen Monotherapy Sales and Market Share by Type
6.4 Germany Antiandrogen Monotherapy Sales and Market Share by Application

7 FRANCE ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 France Antiandrogen Monotherapy Sales and Value (2012-2017)
  7.1.1 France Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  7.1.2 France Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  7.1.3 France Antiandrogen Monotherapy Sales Price Trend (2012-2017)
7.2 France Antiandrogen Monotherapy Sales and Market Share by Manufacturers
7.3 France Antiandrogen Monotherapy Sales and Market Share by Type
7.4 France Antiandrogen Monotherapy Sales and Market Share by Application

8 UK ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 UK Antiandrogen Monotherapy Sales and Value (2012-2017)
  8.1.1 UK Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  8.1.2 UK Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  8.1.3 UK Antiandrogen Monotherapy Sales Price Trend (2012-2017)
8.2 UK Antiandrogen Monotherapy Sales and Market Share by Manufacturers
8.3 UK Antiandrogen Monotherapy Sales and Market Share by Type
8.4 UK Antiandrogen Monotherapy Sales and Market Share by Application

9 RUSSIA ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Antiandrogen Monotherapy Sales and Value (2012-2017)
  9.1.1 Russia Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  9.1.2 Russia Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Antiandrogen Monotherapy Sales Price Trend (2012-2017)
9.2 Russia Antiandrogen Monotherapy Sales and Market Share by Manufacturers
9.3 Russia Antiandrogen Monotherapy Sales and Market Share by Type
9.4 Russia Antiandrogen Monotherapy Sales and Market Share by Application

10 ITALY ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Antiandrogen Monotherapy Sales and Value (2012-2017)
  10.1.1 Italy Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  10.1.2 Italy Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Antiandrogen Monotherapy Sales Price Trend (2012-2017)
10.2 Italy Antiandrogen Monotherapy Sales and Market Share by Manufacturers
10.3 Italy Antiandrogen Monotherapy Sales and Market Share by Type
10.4 Italy Antiandrogen Monotherapy Sales and Market Share by Application

11 SPAIN ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Antiandrogen Monotherapy Sales and Value (2012-2017)
  11.1.1 Spain Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  11.1.2 Spain Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Antiandrogen Monotherapy Sales Price Trend (2012-2017)
11.2 Spain Antiandrogen Monotherapy Sales and Market Share by Manufacturers
11.3 Spain Antiandrogen Monotherapy Sales and Market Share by Type
11.4 Spain Antiandrogen Monotherapy Sales and Market Share by Application

12 BENELUX ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Antiandrogen Monotherapy Sales and Value (2012-2017)
  12.1.1 Benelux Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Antiandrogen Monotherapy Sales Price Trend (2012-2017)
12.2 Benelux Antiandrogen Monotherapy Sales and Market Share by Manufacturers
12.3 Benelux Antiandrogen Monotherapy Sales and Market Share by Type
12.4 Benelux Antiandrogen Monotherapy Sales and Market Share by Application

13 EUROPE ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS

13.1 Pfizer Inc. (USA)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Abbott Laboratories (USA)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Genentech Inc. (USA)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 GlaxoSmithKline Plc (UK)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Immunomedics, Inc. (USA)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Indevus Pharmaceuticals Inc. (USA)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Novartis AG (Switzerland)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 OSI Pharmaceuticals, Inc. (USA)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Paladin Labs Inc. (Canada)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Antiandrogen Monotherapy Market Forecast by Type (2017-2022)
15.9 Europe Antiandrogen Monotherapy Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen Monotherapy
Table Classification of Antiandrogen Monotherapy
Figure Europe Sales Market Share of Antiandrogen Monotherapy by Type in 2016
Table Application of Antiandrogen Monotherapy
Figure Europe Sales Market Share of Antiandrogen Monotherapy by Application in 2016
Figure Germany Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure France Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure UK Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Russia Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Italy Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Spain Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Benelux Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Europe Antiandrogen Monotherapy Sales and Growth Rate (2012-2022)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Table Europe Antiandrogen Monotherapy Sales of Key Manufacturers (2015 and 2016)
Table Europe Antiandrogen Monotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Sales Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Sales Share by Manufacturers
Table Europe Antiandrogen Monotherapy Revenue by Manufacturers (2015 and 2016)
Table Europe Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 Europe Antiandrogen Monotherapy Revenue Share by Manufacturers
Table Europe Antiandrogen Monotherapy Sales and Market Share by Type (2012-2017)
Table Europe Antiandrogen Monotherapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure Europe Antiandrogen Monotherapy Sales Growth Rate by Type (2012-2017)
Table Europe Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
Table Europe Antiandrogen Monotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure Europe Antiandrogen Monotherapy Revenue Growth Rate by Type (2012-2017)
Table Europe Antiandrogen Monotherapy Sales and Market Share by Countries (2012-2017)
Table Europe Antiandrogen Monotherapy Sales Share by Countries (2012-2017)
Figure Sales Market Share of Antiandrogen Monotherapy by Countries (2012-2017)
Table Europe Antiandrogen Monotherapy Revenue and Market Share by Countries (2012-2017)
Table Europe Antiandrogen Monotherapy Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Antiandrogen Monotherapy by Countries (2012-2017)
Table Europe Antiandrogen Monotherapy Sales and Market Share by Application (2012-2017)
Table Europe Antiandrogen Monotherapy Sales Share by Application (2012-2017)
Figure Sales Market Share of Antiandrogen Monotherapy by Application (2012-2017)
Figure Germany Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Germany Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Germany Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Germany Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table Germany Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table Germany Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table Germany Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table Germany Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table Germany Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Figure France Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure France Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure France Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table France Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table France Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table France Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table France Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table France Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table France Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Figure UK Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure UK Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure UK Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table UK Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table UK Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table UK Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table UK Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table UK Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table UK Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Figure Russia Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Russia Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Russia Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Russia Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table Russia Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table Russia Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table Russia Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table Russia Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table Russia Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Figure Italy Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Italy Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Italy Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Italy Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table Italy Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table Italy Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table Italy Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table Italy Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table Italy Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Figure Spain Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Spain Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Spain Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Spain Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table Spain Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table Spain Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table Spain Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table Spain Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table Spain Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Figure Benelux Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Benelux Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Benelux Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Benelux Antiandrogen Monotherapy Sales by Manufacturers (2015 and 2016)
Table Benelux Antiandrogen Monotherapy Market Share by Manufacturers (2015 and 2016)
Table Benelux Antiandrogen Monotherapy Sales by Type (2015 and 2016)
Table Benelux Antiandrogen Monotherapy Market Share by Type (2015 and 2016)
Table Benelux Antiandrogen Monotherapy Sales by Application (2015 and 2016)
Table Benelux Antiandrogen Monotherapy Market Share by Application (2015 and 2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure Germany Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Germany Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure France Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure France Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure UK Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure UK Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Russia Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Italy Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Spain Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Table Europe Antiandrogen Monotherapy Sales Forecast by Type (2017-2022)
Table Europe Antiandrogen Monotherapy Sales Forecast by Application (2017-2022)